Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |